Experiments were performed in order to obtain physiological evidence for the presence of 6 opioid receptors in the guinea pig isolated ileum. The nonequilibrium narcotic antagonists 13chlornaltrexamine (13-CNA) and 3funal-trexamine (,B-FNA) differentially affected inhibitory responses to ,u-and 8specific opiate ligands (q value). These results indicate that these agonists do not act through identical populations of receptor in the ileumn despite the similarity of their naloxone Ke values (apparent naloxone dissociation constant determined physiologically). Moreover, elimination of myenteric ,u receptors resulted in a 10-fold increase in the naloxone Ke for the highly selective 8 agonist Tyr-D-Ser-Gly-Phe-LeuThr, suggesting the involvement of a second receptor subtype. It is suggested that this receptor is 8 in nature.
A variety of experimental approaches have suggested the existence of a multiplicity of classes of opioid receptor in the central and peripheral nervous system that have been classified as A,, 8 , and K (l, 2). Although it is well established that the guinea pig myenteric plexus contains the ,u and K classes, the presence and function of 8 opioid receptors in this nervous structure is controversial. In vitro radioligand binding experiments indicated the presence of discrete 8 binding sites in the guinea pig myenteric plexus (3) . Consistent with these binding data were the observations from our laboratory (4) that the guinea pig ileum manifests differential tolerance to the inhibitory effects of agonists that bind differentially to the ,u and 8 receptors (,a and 8 agonists), suggesting that, at least in tolerant/dependent preparations, the inhibitory effects of these two classes of opioid agonist are mediated through distinct populations of receptor. However, both of these observations are in striking contrast to data obtained from naive ilea, where the naloxone Ke (apparent naloxone dissociation constant determined physiologically) for A and 8 agonists are almost identical (2, 3) , indicating that in these preparations ,u and 8 agonists act through the same class of receptor, the ,u receptor.
One possible explanation for this discrepancy is that, in the guinea pig ileum, several classes of opioid receptor such as ,u and K are associated with the same function, inhibition of release of acetylcholine. Because most receptor-specific agonists do have considerable crossreactivity with one or more of the other classes, the naloxone Ke for a receptorspecific ligand might indicate an interaction with only the class of receptor that is present in largest numbers or that is most efficiently coupled to the process being regulated. Consequently the presence of one class of receptor may prevent the demonstration of the copresence of others, resulting in the masking of differential naloxone sensitivity. The present experiments were performed in order to clarify the apparent discrepancies concerning myenteric 8 receptors and to determine whether the presence of functional 6 receptors in naive ilea are obscured by the copresence of the pu subtype.
MATERIALS AND METHODS
Bioassay for Opioids. An intact segment of guinea pig small intestine was secured in a 3.5-ml jacketed organ bath containing Krebs buffer that was maintained at 370C and bubbled continuously with 95% 02/5% CO2 (4) . With resting tension fixed at 0.5 g, the ileum was stimulated by transmural electrical stimulation with platinum electrodes (4 (8) (9) (10) (11) , respectively. The concentration of P3-CNA and ,B-FNA were chosen such that the maximal response to each opioid agonist was depressed between 20% and 80% (5) . From each pair of curves, A and A' were obtained, the reciprocals of which were plotted against each other. These data were analyzed by linear regression, and q was obtained by calculating the inverse of the slope. In all cases, the coefficient of linearity was 0.95 or greater.
Calculation of Naloxone Ke. Concentrations of agonist producing a 50% inhibition (IC50) of the 0.1-Hz contraction were determined by testing at three or more concentrations giving 20-80% inhibition and interpolating by log-linear regression analysis. The apparent naloxone dissociation constant, Ke, was calculated from the equation Ke = C/(DR -1) (12) in which the concentration (C) of naloxone is 10 nM and DR is the ratio of IC50 values for the agonist in the presence and absence of antagonist. In order to obtain preparations that were functionally devoid of , receptors, segments of ileum were treated with the ,t-receptor-selective nonequilibrium antagonist (3-FNA (1 uM for 60 min) as described (11) after which dose-response curves to the above agonists were constructed. The naloxone Ke was determined as described above except that, because of the diminished responsiveness to P,-receptor (normorphine) and 8- 
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RESULTS
Differential Sensitivity of Receptor-Subtype-Specific Ligands to 13-CNA and 13-FNA. The q value indicates the percentage of receptors remaining functional after irreversible inactivation provided the agonist interacts with a single homogeneous population of receptor (5) . In the case of agonists that interact with a heterogeneous population of receptor, differences in their respective q values would reflect differential inactivation of the receptor types through which each ligand acts (5). Accordingly, populations of receptor mediating responses to A (morphine) and 8 (DADLE) agonists were compared on the basis of their reactivity with the nonequilibrium antagonist /3-CNA by calculating their respective q values (Table 1 ). In addition, the q values for the somewhat more selective ligands normorphine and DSLET (14) were calculated and compared after exposure to the p-receptorselective nonequilibrium antagonist ,f3FNA (Table 2) . Exposure of segments of intestine to 40 nM f3-CNA resulted in a differential inactivation of the receptors mediating responses to morphine and DADLE (Table 1) . Similar results were obtained for normorphine and DSLET in ilea treated with 1 AM ,13FNA (Table 2 ). In both cases the q values obtained for each p-receptor-preferring ligand differed significantly (P < 0.05) from that obtained for the corresponding 8 specific agonist that was determined in parallel. This indicates that, despite the similarity of the naloxone Ke for morphine, normorphine, DADLE, and DSLET (see Table 3 ), the population(s) of receptor mediating responses to these A-and 8-receptorpreferring agonists are not identical (i.e., they can be distinguished on the basis of their sensitivity to P-CNA and f3-FNA).
Effect of Exposure to 13-FNA on the DSLET Naloxone Ke. It is well established that ligands such as DADLE and DSLET have considerable crossreactivity with , receptors. Thus, it seemed plausible that the presence of A receptors might obscure the demonstration of functional 8 receptors in naive ilea, resulting in similar naloxone Ke values for ,-and 8-receptor-preferring ligands. In order to investigate this possibility, responses to DSLET were analyzed in ilea functional- Table 2 . q value after exposure to P-FNA % depression of Agonist q maximum response Normorphine 0.24 ± 0.05 (7)* 47.9 ± 3.2 DSLET 0.1 ± 0.04 (7) 56.0 ± 3.7 Dose-response curves to normorphine and DSLET were constructed in parallel on contiguous segments of intestine before and after exposure to ,3-FNA at 1 ,uM for 30 min from which q values were calculated as described. Values in parentheses are the numbers of experiments. *P < 0.05 vs. DSLET. which the concentration (C) of naloxone is 10 nM and DR is the ratio of IC50 values for the agonist in the presence and absence of antagonist. Segments of ileum were treated with 1 ,uM ,B-FNA for 60 min as described (11) after which dose-response curves to the above agonists were constructed. The naloxone Ke was determined as described above except that normorphine and DSLET concentrations producing a 10-30% inhibition were used. EKC, ethylketocyclazocine.
ly devoid of A receptors. Such preparations were generated by pretreating ilea with 1 ,uM of the ,u-selective nonequilibrium antagonist ,B-FNA for 60 min. This procedure has been reported (11) and was confirmed in the present study to be more than sufficient to functionally eliminate all the myenteric A receptors. Concentrations of ,¢FNA in excess of 0.1 AM failed to produce any additional shift to the right in the normorphine dose-response curve. Moreover, the naloxone Ke for normorphine after treatment with 1-FNA at 1 AM (see Table 3 ) indicated that it was no longer acting through , receptors. Elimination of u receptors substantially attenuated but did not abolish responses to DSLET; approximately 38% of the maximum inhibitory response remained (Fig. 1) . These data would indicate that, in addition to , receptors, DSLET can also act through another class of receptor to inhibit 0.1-Hz ileal contractions.
The nature of the receptor mediating the B-FNA-resistant response to DSLET was investigated by determining its naloxone Ke after pretreatment with this ,-receptor-selective nonequilibrium antagonist. Fig. 2 illustrates the dose-response relationship to DSLET in a ",-less" preparation before and after treatment with naloxone. p-FNA-resistant responses to DSLET can be antagonized by naloxone such that there is a parallel shift to the right in the DSLET doseresponse curve. From this parallel shift, the naloxone Ke for DSLET in the absence of , receptors can be determined. Table 3 Concentration, ,tM Tables 1 and   2 ). Because occupation of several different classes of myenteric opioid receptor can produce similar physiological effects, the presence of one kind may obscure the demonstration of the others. Thus, it is necessary to eliminate myenteric ,u receptors before one can discern the involvement of the other class through which DSLET can inhibit ileal contractions. Pretreatment for 1 hr with ,B-FNA at 1 ,M substantially attenuates but does not abolish responses to DSLET. Moreover, the naloxone Ke of the response remaining is approximately an order of magnitude higher than that observed in untreated ilea. Therefore, elimination of the , receptor facilitates the demonstration of a second receptor through which DSLET inhibits 0.1-Hz contractions.
The precise nature of the class of opioid receptor mediating f&FNA-resistant responses to DSLET has not been unequivocably established because both 8 and K receptors remain functional after exposure to P-FNA (11) . However, the extremely small crossreactivity between 8-receptor-preferring agonists (DADLE and DSLET) and the K class strongly suggests, but does not prove, that the -3-FNA-resistant inhibitory response to DSLET is mediated through myenteric 8 receptors.
